IHAM
Integral Health Asset Management’s Boston Scientific BSX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $59.1M | Sell |
550,000
-100,000
| -15% | -$10.7M | 5.41% | 2 |
|
|
2025
Q1 | $65.6M | Buy |
650,000
+100,000
| +18% | +$10.1M | 6.98% | 2 |
|
|
2024
Q4 | $49.1M | Hold |
550,000
| – | – | 4.19% | 3 |
|
|
2024
Q3 | $46.1M | Sell |
550,000
-100,000
| -15% | -$8.38M | 5.19% | 3 |
|
|
2024
Q2 | $50.1M | Buy |
650,000
+50,000
| +8% | +$3.85M | 4.76% | 4 |
|
|
2024
Q1 | $41.1M | Buy |
600,000
+225,000
| +60% | +$15.4M | 3.81% | 2 |
|
|
2023
Q4 | $21.7M | Sell |
375,000
-175,000
| -32% | -$10.1M | 2.95% | 6 |
|
|
2023
Q3 | $29M | Buy |
550,000
+84,000
| +18% | +$4.44M | 4.02% | 3 |
|
|
2023
Q2 | $25.2M | Buy |
466,000
+314,000
| +207% | +$17M | 3.12% | 5 |
|
|
2023
Q1 | $7.6M | Buy |
+152,000
| New | +$7.6M | 1.53% | 28 |
|
|
2022
Q4 | – | Sell |
-350,000
| Closed | -$13.6M | – | 68 |
|
|
2022
Q3 | $13.6M | Buy |
+350,000
| New | +$13.6M | 2.63% | 11 |
|
|
2020
Q2 | – | Sell |
-125,000
| Closed | -$4.08M | – | 63 |
|
|
2020
Q1 | $4.08M | Sell |
125,000
-75,000
| -38% | -$2.45M | 1.8% | 21 |
|
|
2019
Q4 | $9.04M | Buy |
+200,000
| New | +$9.04M | 3.52% | 9 |
|